saphenous vein grafts

Original Contribution

Real World Single Center Experience With Saphenous Vein Grafts Interventions: Should Filters be Filtered out?

07/10/2023

Adnan Kassier , MD;

Ronak Soni , MD;

Kameel Kassab , MD;

Dilpat Kumar , MBBS;

Yashwant Agrawal , MD, FACC, FSCAI;

Veera Pavan Kotaru , MD;

Frank Saltiel , MD;

Tim A. Fischell , MD, FACC, FSCAI;

Jagadeesh K. Kalavakunta , MD;

Vishal Gupta , MD, MPH;

Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) can be challenging due to no reflow phenomenon from distal embolization of debris and microvascular vasoconstriction, resulting in myocardial injury post-procedure....

Percutaneous coronary...

07/10/2023

Journal of Invasive Cardiology

Original Contribution

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial

10/01/2015

Anna P. Kotsia , MD, PhD;

Georgios Christopoulos , MD;

James A. de Lemos , MD;

Darren K. McGuire , MD, MHSc;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Milton Packer , MD;

Subhash Banerjee , MD, FSCAI;

Daisha J. Cipher , PhD, MD;

Michele Roesle , RN, BSN, MD;

Bavana V. Rangan , BDS, MPH, MD;

Ameka Coleman , MS, BS;

Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.

Intermediate SVG lesions have...

10/01/2015

Journal of Invasive Cardiology